pipette
ENEnglish

Synthesis-aware generative design in trillion-scale chemical spaces for automated drug discovery

S. Seo, Y. Sung, S.-Y. Hwang, M. Kang, J. Lee, S. Bordi, L. Raguz, J. Choi, D. Melnichenko, W. Namkung, S. Lee, J. Lim, B. M. Wanner, J. M. Han, W. Y. Kim

PreprintAfirmaciones fuertes, leer con cuidadoDice ser un gran avanceUso en el mundo real

En palabras de los autores

Autonomous drug discovery via generative molecular design is critically bottlenecked by the production of chemically intractable structures. Multi-trillion-scale make-on-demand libraries guarantee synthetic feasibility, but conventional virtual screening cannot efficiently navigate these vast spaces or address multi-parameter optimization. We introduce Hyper Screening X, a generative AI framework integrating structure-based design with automated synthesis hardware. By encoding deterministic reaction logic in a generative flow network, the framework evaluates only 10 million candidates to navigate an 11-trillion-compound space, jointly optimizing physicochemical properties while ensuring compatibility with automated synthesis. Prospective validation against an SLC1A5 variant with a cryptic interface yielded a 96% synthesis success rate and a 50% functional hit rate, identifying two first-in-class lead compounds. This synthesis-aware strategy advances autonomous, closed-loop drug discovery.

Resultado principalEl resumen no menciona limitaciones.

Apareció: viernes, 9 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.01.755933